Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.00792452830188682 -0.00792452830188682 -0.00415094339622639 -0.0010377358490566
Stock impact report

Cancer Research Highlight: AstraZeneca's Checkpoint Combo Fails To Help In Head And Neck [Seeking Alpha]

Bristol-Myers Squibb Company (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
Company Research Source: Seeking Alpha
Please note that I am affiliated with Avisol Capital Partners and their Total Pharma Tracker service. They have also covered the companies in this article in their writings, and I wanted to make readers aware of the potential for overlapping coverage. If you're interested in this service, you can try a free two-week trial today! All along the year 2018, AstraZeneca ( AZN ) has posted challenges in developing their PD-L1 inhibitor durvalumab. While they scored a huge hit with their approval in stage III non-small cell lung cancer (and updated data from PACIFIC continue to affirm that the drug is making a big difference when given after chemotherapy and radiation), it has failed to make a mark in other areas. Recall that we got final confirmation that the phase 3 MYSTIC study was a failure, as durvalumab and tremelimumab did not improve survival in patients with metastatic non-small cell lung cancer. Still, the work continues to find other viable niches for the Show less Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BMY alerts
Opt-in for
BMY alerts

from News Quantified
Opt-in for
BMY alerts

from News Quantified